Why the study?
This review aimed to revise the definition of D-dimer, discuss preanalytical and postanalytical variables affecting its measurement, compare assay performance, and examine clinical applications.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
D-dimer interpretation requires attention to preanalytical variables; review extends synthesis but leaves open standardization needs.
D-dimer is a soluble fibrin degradation product deriving from the plasmin-mediated degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of activation of coagulation and fibrinolysis, and it is routinely used for ruling out venous thromboembolism (VTE). D-dimer is increasingly used to assess the risk of VTE recurrence and to help define the optimal duration of anticoagulation treatment in patients with VTE, for diagnosing disseminated intravascular coagulation, and for screening medical patients at increased risk of VTE. This review is aimed at (1) revising the definition of D-dimer; (2) discussing preanalytical variables affecting the measurement of D-dimer; (3) reviewing and comparing assay performance and some postanalytical variables (e.g. different units and age-adjusted cutoffs); and (4) discussing the use of D-dimer measurement across different clinical settings.
No takes yet. Share an insight, caveat, or question.
Favresse et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: